$AWH
Aspira Women's Health Inc.

2020 Q3 Form 10-Q Financial Statement

#000092661720000063 Filed on August 14, 2020

View on sec.gov

Income Statement

Concept 2020 Q3 2020 Q2 2019 Q4
Revenue $1.239M $746.0K $1.310M
YoY Change -3.58% -34.68% 42.39%
Cost Of Revenue $807.0K $593.0K $790.0K
YoY Change -14.96% -34.69% 5.33%
Gross Profit $432.0K $153.0K $520.0K
YoY Change 28.57% -34.62% 205.88%
Gross Profit Margin 34.87% 20.51% 39.69%
Selling, General & Admin $4.118M $3.599M $3.680M
YoY Change 7.07% -16.57% 28.22%
% of Gross Profit 953.24% 2352.29% 707.69%
Research & Development $595.0K $380.0K $240.0K
YoY Change 75.0% 68.89% 84.62%
% of Gross Profit 137.73% 248.37% 46.15%
Depreciation & Amortization $70.00K $50.00K $50.00K
YoY Change 16.67% -50.0% -66.67%
% of Gross Profit 16.2% 32.68% 9.62%
Operating Expenses $4.713M $3.979M $3.920M
YoY Change 12.59% -12.34% 30.67%
Operating Profit -$4.281M -$3.826M -$3.400M
YoY Change 11.19% -11.13% 20.14%
Interest Expense $10.00K $0.00 $20.00K
YoY Change -66.67%
% of Operating Profit
Other Income/Expense, Net -$11.00K -$6.000K $0.00
YoY Change 175.0% -14.29%
Pretax Income -$4.290M -$3.830M -$3.390M
YoY Change 12.3% -11.14% 20.21%
Income Tax
% Of Pretax Income
Net Earnings -$4.287M -$3.831M -$3.390M
YoY Change 12.23% -11.2% 20.21%
Net Earnings / Revenue -346.0% -513.54% -258.78%
Basic Earnings Per Share
Diluted Earnings Per Share -$41.57K -$39.03K -$34.83K
COMMON SHARES
Basic Shares Outstanding 103.8M 97.38M 97.24M
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q3 2020 Q2 2019 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $18.80M $10.90M $11.70M
YoY Change 28.77% -32.72% 24.47%
Cash & Equivalents $18.84M $10.94M $11.70M
Short-Term Investments
Other Short-Term Assets $500.0K $900.0K $800.0K
YoY Change 25.0% 80.0% 33.33%
Inventory $0.00 $100.0K $25.00K
Prepaid Expenses
Receivables $848.0K $800.0K $924.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $20.25M $12.70M $13.41M
YoY Change 26.17% -27.7% 24.3%
LONG-TERM ASSETS
Property, Plant & Equipment $1.000M $400.0K $353.0K
YoY Change 150.63% -15.25% -41.94%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00 $41.00K $13.00K
YoY Change -100.0% -64.35% 8.33%
Total Long-Term Assets $1.014M $391.0K $418.0K
YoY Change 109.94% -33.39% -32.58%
TOTAL ASSETS
Total Short-Term Assets $20.25M $12.70M $13.41M
Total Long-Term Assets $1.014M $391.0K $418.0K
Total Assets $21.27M $13.09M $13.83M
YoY Change 28.62% -27.88% 21.21%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.315M $1.122M $855.0K
YoY Change 46.11% 38.35% -10.0%
Accrued Expenses $2.815M $2.459M $2.588M
YoY Change 17.15% -0.57% 41.81%
Deferred Revenue
YoY Change
Short-Term Debt $476.0K $587.0K $303.0K
YoY Change 138.0% 207.33% 60.32%
Long-Term Debt Due $193.0K
YoY Change
Total Short-Term Liabilities $4.600M $4.199M $3.978M
YoY Change 30.05% 17.92% 34.21%
LONG-TERM LIABILITIES
Long-Term Debt $1.700M $1.615M $1.099M
YoY Change 48.08% 35.03% -14.94%
Other Long-Term Liabilities $400.0K $10.00K $13.00K
YoY Change 1804.76% -65.52%
Total Long-Term Liabilities $2.100M $1.625M $1.112M
YoY Change 79.64% 32.65% -13.93%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.600M $4.199M $3.978M
Total Long-Term Liabilities $2.100M $1.625M $1.112M
Total Liabilities $6.700M $5.824M $5.090M
YoY Change 42.37% 21.69% 19.6%
SHAREHOLDERS EQUITY
Retained Earnings -$434.0M -$429.7M -$422.2M
YoY Change 3.63% 3.55% 3.74%
Common Stock $101.0K $97.00K
YoY Change 7.45% 29.33%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $14.55M $7.267M $8.738M
YoY Change
Total Liabilities & Shareholders Equity $21.30M $13.09M $13.83M
YoY Change 28.83% -27.88% 21.21%

Cashflow Statement

Concept 2020 Q3 2020 Q2 2019 Q4
OPERATING ACTIVITIES
Net Income -$4.287M -$3.831M -$3.390M
YoY Change 12.23% -11.2% 20.21%
Depreciation, Depletion And Amortization $70.00K $50.00K $50.00K
YoY Change 16.67% -50.0% -66.67%
Cash From Operating Activities -$3.070M -$3.410M -$2.880M
YoY Change -10.76% -3.67% 25.22%
INVESTING ACTIVITIES
Capital Expenditures -$150.0K -$100.0K -$10.00K
YoY Change 275.0% 233.33% -80.0%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities -$150.0K -$100.0K -$10.00K
YoY Change 275.0% 233.33% -80.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 11.11M 6.320M -50.00K
YoY Change 472.68% -53.46% 0.0%
NET CHANGE
Cash From Operating Activities -3.070M -3.410M -2.880M
Cash From Investing Activities -150.0K -100.0K -10.00K
Cash From Financing Activities 11.11M 6.320M -50.00K
Net Change In Cash 7.890M 2.810M -2.940M
YoY Change -612.34% -71.93% 22.5%
FREE CASH FLOW
Cash From Operating Activities -$3.070M -$3.410M -$2.880M
Capital Expenditures -$150.0K -$100.0K -$10.00K
Free Cash Flow -$2.920M -$3.310M -$2.870M
YoY Change -14.12% -5.7% 27.56%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
awh Net Increase Decrease In Other Assets Or Other Liabilities For Right Of Use Assets
NetIncreaseDecreaseInOtherAssetsOrOtherLiabilitiesForRightOfUseAssets
115000
awh Net Increase Decrease In Other Assets Or Other Liabilities For Right Of Use Assets
NetIncreaseDecreaseInOtherAssetsOrOtherLiabilitiesForRightOfUseAssets
11000
awh Percentage Of Royalty Paid
PercentageOfRoyaltyPaid
0.04
awh Proceeds From Paycheck Protection Program Loan
ProceedsFromPaycheckProtectionProgramLoan
1006000
CY2020Q2 awh Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
5060000
dei Amendment Flag
AmendmentFlag
false
dei City Area Code
CityAreaCode
512
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Document Period End Date
DocumentPeriodEndDate
2020-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Document Type
DocumentType
10-Q
dei Entity Address Address Line1
EntityAddressAddressLine1
12117 Bee Caves Road
dei Entity Address Address Line2
EntityAddressAddressLine2
Building Three
dei Entity Address Address Line3
EntityAddressAddressLine3
Suite 100
dei Entity Address City Or Town
EntityAddressCityOrTown
Austin
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
78738
dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
6819000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-768000
dei Entity Central Index Key
EntityCentralIndexKey
0000926617
CY2020Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
103820090
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Trading Symbol
TradingSymbol
AWH
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1158000
CY2020Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1122000
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
924000
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16179000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11703000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10935000
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity File Number
EntityFileNumber
001-34810
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Registrant Name
EntityRegistrantName
Aspira Women's Health Inc.
dei Entity Shell Company
EntityShellCompany
false
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
33-0595156
dei Local Phone Number
LocalPhoneNumber
519-0400
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2588000
CY2020Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2459000
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
430802000
CY2020Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
436864000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10069924
CY2019Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2019Q4 us-gaap Assets
Assets
13828000
CY2020Q2 us-gaap Assets
Assets
13091000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
13410000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9360000
CY2020Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
97286157
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
100525090
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
97286157
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
100525090
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
97000
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
101000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1602000
CY2019Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
908000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1393000
CY2020Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
593000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.11
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.06
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.08
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.04
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
215000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
114000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-3000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-2000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2789000
CY2019Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1534000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3576000
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1866000
us-gaap Gross Profit
GrossProfit
343000
CY2019Q2 us-gaap Gross Profit
GrossProfit
234000
us-gaap Gross Profit
GrossProfit
573000
CY2020Q2 us-gaap Gross Profit
GrossProfit
153000
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
79000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
509000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-165000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
14000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-105000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-2000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
41000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-66000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
99000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
5000
CY2019Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-2000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
9000
CY2020Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
1000
us-gaap Interest Paid Net
InterestPaidNet
21000
us-gaap Interest Paid Net
InterestPaidNet
18000
CY2019Q4 us-gaap Inventory Net
InventoryNet
25000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
18000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
1000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
4000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
4000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
4000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
18000
CY2020Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
9000
CY2019Q4 us-gaap Liabilities
Liabilities
5090000
CY2020Q2 us-gaap Liabilities
Liabilities
5824000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
13828000
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
13091000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
49000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3978000
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
4199000
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1099000
CY2020Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1615000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
13553000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6265000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-82000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-123000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6652000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6910000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-3716000
us-gaap Net Income Loss
NetIncomeLoss
-8030000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-4314000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-3706000
us-gaap Net Income Loss
NetIncomeLoss
-7537000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-3831000
us-gaap Operating Expenses
OperatingExpenses
8367000
CY2019Q2 us-gaap Operating Expenses
OperatingExpenses
4539000
us-gaap Operating Expenses
OperatingExpenses
8199000
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
3979000
us-gaap Operating Income Loss
OperatingIncomeLoss
-8024000
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-4305000
us-gaap Operating Income Loss
OperatingIncomeLoss
-7626000
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3826000
CY2020Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
40000
CY2020Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0863
CY2020Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y1M6D
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-422161000
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-429698000
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
65000
CY2020Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
41000
CY2019Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
39000
CY2020Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
31000
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
13000
CY2020Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
10000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-11000
CY2019Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-7000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
80000
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-6000
us-gaap Payments For Royalties
PaymentsForRoyalties
57500
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
82000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
123000
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
758000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
13630000
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
5059000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
17000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
296000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
353000
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
94000
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
96000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
434000
CY2019Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
225000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
775000
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
380000
us-gaap Revenues
Revenues
1945000
CY2019Q2 us-gaap Revenues
Revenues
1142000
us-gaap Revenues
Revenues
1966000
CY2020Q2 us-gaap Revenues
Revenues
746000
us-gaap Royalty Expense
RoyaltyExpense
75000
us-gaap Royalty Expense
RoyaltyExpense
76000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
5144000
CY2019Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2780000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3848000
CY2020Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1733000
us-gaap Share Based Compensation
ShareBasedCompensation
597000
CY2019Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
13630000
CY2019Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
3000
us-gaap Share Based Compensation
ShareBasedCompensation
711000
CY2019Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
193000
CY2020Q2 us-gaap Short Term Borrowings
ShortTermBorrowings
587000
CY2019Q1 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
181000
CY2019Q2 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
290000
CY2020Q1 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
269000
CY2020Q2 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
320000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
7152000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
3637000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
13366000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
8738000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
5302000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
7267000
CY2019Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
123000
CY2020Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
121000
CY2019Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
17000
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
295000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
75860411
CY2019Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
76205894
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
97707904
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
98123789

Files In Submission

Name View Source Status
0000926617-20-000063-index-headers.html Edgar Link pending
0000926617-20-000063-index.html Edgar Link pending
0000926617-20-000063.txt Edgar Link pending
0000926617-20-000063-xbrl.zip Edgar Link pending
awh-20200630.xml Edgar Link completed
awh-20200630.xsd Edgar Link pending
awh-20200630x10q.htm Edgar Link pending
awh-20200630xex31_1.htm Edgar Link pending
awh-20200630xex31_2.htm Edgar Link pending
awh-20200630xex32_1.htm Edgar Link pending
awh-20200630_cal.xml Edgar Link unprocessable
awh-20200630_def.xml Edgar Link unprocessable
awh-20200630_lab.xml Edgar Link unprocessable
awh-20200630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending